SELECTIS HEALTH, INC.

GBCS
About the company

Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States. The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements.

Country: United StatesPrice: $5.73Market Cap: $17.6M

Investment snapshot

0%positive consensus
Scored 1d ago

Positive

0

BUY / PASS

Neutral / negative

4 / 12

NEUTRAL / FAIL

Median fair value

$7.96

+38.9% vs price

Models with upside

2 / 17

Positive margin of safety

Strongest signal

Models split on GBCS at $5.73 — fair values range $0.06–$8.54

Key risk

No clean pass — all 13 investors flag at least one valuation criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2310 (Top 74.6%)NEUTRALFAILFAILFAILFAILFAILFAILFAILNEUTRALNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A-9450.0%N/AN/AN/AN/A+32.9%N/AN/AN/A+28.0%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Annual history · FY 2025

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30 · TTM ended 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

TTM ended 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-10-01

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-06-30 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Market data at 2026-10-01

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-10-01 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-15

Score computed: 2026-11-14

TTM ended 2026-06-30 · Balance sheet at 2026-06-30 · Price history 2025-01-01–2026-10-01 · Annual history · FY 2025

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-06-30

Latest source filing: 2026-08-24

Score computed: 2026-11-14

TTM ended 2026-06-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-10-01

Latest source filing: 2026-08-24

Score computed: 2026-11-14

Where It Passes

  • Valuation models67% pass✓ 2✗ 1▾

    Models split on GBCS at $5.73 — fair values range $0.06–$8.54

    Buffett fair value$0.06
    ✗Buffett-9450.0% margin vs $5.73
    Munger fair value$8.54
    ✓Munger+32.9% margin vs $5.73
    Ackman fair value$7.96
    ✓Ackman+28.0% margin vs $5.73

Where It Falls Short

  • Valuation0% pass✓ 2✗ 23▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / FFO per Share38.3x
    ✗Graham<= 15x✗Dreman< 12x✗Ackman<= 25
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-15.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-15.1%, ROC=-25.4%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / (CFO / Shares)9.3x
    ✗Dreman< 8x
    Valuation ReasonablenessOE Yield=0.1%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/FFO or FFO YieldP/FFO=38.3x, FFO Yield=2.6%
    ✗PabraiP/FFO < 15 or FFO Yield > 10%
    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / EPS
    ✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price vs. Trailing Low379% of trailing low ($1.51)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Price / Book Value per ShareN/A (negative BVPS)
    ✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Net income / market capitalization+83.06%; #104/6340 (top 1.6%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.4537; #3055/6449 (top 47.4%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+1.8509; #1152/5247 (top 22.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-22.03%; #3549/4519 (top 78.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+27.33%; #1095/6202 (top 17.7%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts0% pass✗ 13▾

    Split decision: 12 FAIL · 4 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (0/7)✗BuffettFAIL (1/9)✗LynchFAIL (2/7)✗GreenblattRank #2310•PiotroskiNEUTRAL (F-Score 7)✗DremanFAIL (1/10)✗MungerFAIL (0/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✗TempletonFAIL (2/8)•SleepNEUTRAL (4/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked)
  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag GBCS's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current AssetsLT Debt $11.6M vs NCA $0.2M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 2.13, IC: -1.9x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity2.13
    ✗Lynch< 0.33
    Cash - Long-term Debt$-3.9M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change57.20% -> 41.16%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.02
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity2.13
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels2.13
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-0.9x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity2.13
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-2.1320; #3807/4210 (top 90.4%)
    ✗AsnessTop 30% of eligible cross-section
  • Profitability13% pass✓ 12✗ 23▾

    14 of 16 flag GBCS's profitability — Graham, Buffett, Lynch +11 more

    Positive EPS (10 years)4/19 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)4/19 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-111.3%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-3.8% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$0.0M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE183.1%
    ✓Lynch> 15%
    EBIT / Enterprise Value-15.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-15.1%, ROC=-25.4%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-3.12%
    ✗PiotroskiROA > 0
    ROA Change YoY-7.25% -> -3.12% (delta: +4.13%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=5.78%, ROA=-3.12%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-2.4%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity183.1%
    ✓Dreman> 12%
    Margin of SafetyP/FFO=38.3x
    ✗PabraiP/FFO < 15
    Return on Equity-79.2% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency4/17 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-12.5%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity183.1%
    ✓Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-24.4% (2023) -> -3.8% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin -24.4% -> -3.8%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+83.06%; #104/6340 (top 1.6%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+183.09%; #38/5226 (top 0.7%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0226; #1582/5884 (top 26.9%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years1/10 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth13% pass✓ 3✗ 10▾

    7 of 8 flag GBCS's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency4/17 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth4.9%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin -24.4% -> -3.8%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR14.6%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Efficiency13% pass✓ 2✗ 9▾

    7 of 8 flag GBCS's efficiency — Graham, Buffett, Greenblatt +4 more

    Current Ratio1.02
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-7.6%
    ✗Buffett> 10%
    ROIC - WACC-17.6%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-25.4%
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.18 -> 0.30
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY1.18x -> 1.27x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities1.02
    ✗Dreman> 1.5
    Return on Invested Capital-12.8%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-21.2%; FY2024: ROIC=-8.1%; FY2025: ROIC=-5.0%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -5.0%)
    ✗SleepROIC > 12% in a majority of years
  • Cash Flow33% pass✓ 3✗ 4▾

    4 of 6 flag GBCS's cash flow — Dreman, Sleep, Neff +1 more

    Free Cash Flow Proxy$0.0M
    ✓BuffettPositive and growing
    Operating Cash Flow$1.9M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=5.78%, ROA=-3.12%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)9.3x
    ✗Dreman< 8x
    Positive Operating Cash Flow frequency9/16 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-3.9M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-22.03%; #3549/4519 (top 78.5%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Trading
SIC Sector: Holding & Investment Offices
Size: Micro Cap($17.6M)
Revenue: $41.4M+4.9% YoY
Net Income: $1.0M+58.1% YoY

Financial Snapshot

Operating Margin-3.8%
Return on Equity16.4%
Debt / Equity-4.98
Current Ratio0.30
EPS (Diluted)$-0.34
Shares Retired0.0% / 0.0% 2y

Similar Companies

OREALTY INCOME CORP
$56.1B
VTRVentas, Inc.
$47.0B
RJFRAYMOND JAMES FINANCIAL INC
$32.4B
RGLDROYAL GOLD INC
$21.7B
Sector-adjusted criteria: REIT

Depreciation distorts REIT earnings and book value, so FFO-based criteria replace P/E and free-cash-flow tests, and P/B tests are omitted.

Shareholder Return

Fiscal 2025

Retired 0.0% of shares last year, 0.0% over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-06-30

2025-07-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, revenue, net income, operating income, ebit, interest expense, buybacks.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, buybacks.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-04-15
FY 2024
Sources
  • 10-K · 2025-04-15
FY 2023
Sources
  • 10-K · 2024-04-16
FY 2022
Sources
  • 10-K · 2023-06-30
FY 2021
Sources
  • 10-K · 2022-08-26
Market Cap$17.6Mcurrent----$7.7Mest.$6.1Mest.$11.5Mest.$14.0Mest.$22.4Mest.
Revenue$32.5M↓21%$4.7M↓55%$7.3M↓30%$41.4M↑5%$39.5M↑7%$36.8M↓9%$40.6M↑39%$29.3M
Operating Income-$4.1M↓89%-$2.1M↓367%-$1.3M↓199%-$1.6M↑43%-$2.7M↑70%-$9.0M↓3027%-$286.6K↑61%-$729.0K
Net Income$14.6M↑564%$8.1M↑2737%$6.5M↑1095%-$1.0M↑58%-$2.4M↑39%-$4.0M↓66%-$2.4M↓6%-$2.3M
EPS (Diluted)--$2.35↑2450%$1.90↑964%$-0.34↑57%$-0.80↑39%$-1.31↓66%$-0.79↑4%$-0.82
Gross Margin————————
Operating Margin-12.5%↓141%-44.5%↓931%-17.3%↓331%-3.8%↑45%-6.9%↑72%-24.4%↓3351%-0.7%↑72%-2.5%
ROE183.1%↑272%——16.4%↓63%44.8%↓67%134.0%↑153%-251.4%↓246%-72.6%
Total Debt$17.0M↓43%$17.0M↓43%$17.2M↓43%$30.9M↓4%$32.1M↓12%$36.3M↓1%$36.7M↑18%$31.2M
Shareholders' Equity$8.0M↑225%$8.0M↑225%$258.3K↑104%-$6.2M↓15%-$5.4M↓83%-$3.0M↓411%$952.8K↓69%$3.1M
Current Ratio1.02↑440%1.02↑440%0.60↑173%0.30↑67%0.18↓34%0.27↓62%0.72↑7%0.68
Debt / Equity2.13↑145%2.13↑145%66.59↑1434%-4.98↑16%-5.94↑52%-12.26↓132%38.51↑283%10.06
Operating Cash Flow-$3.4M↓391%-$2.0M↓2531%-$2.3M↓321%$1.9M↑203%-$1.8M↓440%$536.7K↑276%-$305.1K↓13%-$270.9K
Free Cash Flow-$3.9M-$2.1M↓758%-$2.7M↓427%$1.4M↑177%-$1.9M↓467%$506.9K↑196%-$527.5K↑33%-$790.5K

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Trading

GBCS vs Peers — Financial Grading

Revenue$41.4MBottom 25%
Net Income$1.0MBottom 25%
ROE16.4%Top 25%
D/E-4.98Top 25%
Op. Margin-3.8%Bottom 25%
Curr. Ratio0.30Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
REALTY INCOME CORPO$56.1B$58.82$5.7B$1.1B2.7%0.6316.8%—2/71/93/70/3F-Score 64/10
Ventas, Inc.VTR$47.0B$88.92$5.8B$261.5M2.1%1.043.5%—2/71/92/70/3F-Score 62/10
RAYMOND JAMES FINANCIAL INCRJF$32.4B$168.64$15.9B$2.1B17.1%0.28——3/93/93/71/3F-Score 64/11
ROYAL GOLD INCRGLD$21.7B$256.89$1.0B$466.3M6.5%0.1361.9%3.124/92/94/70/3F-Score 44/11
iShares Ethereum Trust ETFETHA$19.4B$44.02—$2.3B——————————
KIMCO REALTY CORPKIM$17.0B$25.55$2.1B$584.7M5.6%0.7436.0%—3/72/94/70/3F-Score 75/10
LandBridge Co LLCLB$5.6B$73.15$199.1M$30.1M8.9%1.6559.5%4.872/93/92/70/3F-Score 63/11
Digital Turbine, Inc.APPS$927.6M$7.61$565.3M$37.7M-19.6%1.886.0%1.161/92/92/71/3F-Score 70/11